全球基因检测市场规模、份额、趋势和成长分析报告（2026-2034年）

基因检测市场预计将从 2025 年的 190.8 亿美元成长到 2034 年的 1,228.3 亿美元，2026 年至 2034 年的复合年增长率为 22.99%。

受个人化医疗和疾病早期检测需求不断增长的推动，全球基因检测市场正经历强劲增长。基因检测透过分析DNA来识别遗传性疾病、基因突变和潜在的健康风险。这些检测广泛应用于遗传性疾病的诊断、癌症风险评估、产前筛检和祖源分析。

基因组学，特别是次世代定序的进步，显着提高了基因检测的速度和准确性。医疗服务提供者越来越多地利用基因数据来制定标靶治疗方案并预测疾病感受性。预防医学意识的提高和基因检测服务可近性的增强也促进了市场扩张。

未来，随着精准医疗的普及，基因检测市场预计将快速成长。基因组研究投入的增加和定序成本的降低将使基因检测更加普及。随着医疗体係向个人化医疗转型，基因检测将成为现代医学的重要组成部分。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球基因检测市场：依技术划分

• 市场分析、洞察与预测
• 次世代定序
• 阵列技术
• 基于PCR的检测
• FISH
• 其他的

第五章 全球基因检测市场：依应用领域划分

• 市场分析、洞察与预测
• 祖籍/民族
• 性状筛检
• 遗传疾病带因者检测

第六章：全球基因检测市场：依新生儿筛检

• 市场分析、洞察与预测
• 健康与保健

第七章 全球基因检测市场：依产品划分

• 市场分析、洞察与预测
• 消耗品
• 装置
• 软体服务

第八章 全球基因检测市场：依通路划分

• 市场分析、洞察与预测
• 在线的
• 离线

第九章 全球基因检测市场：依最终用途划分

• 市场分析、洞察与预测
• 医院和诊所
• 诊断检查室
• 其他的

第十章 全球基因检测市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第十一章 竞争格局

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十二章：公司简介

• 主要公司的市占率分析
• 公司简介
  • 24Genetics
  • Circle DNA
  • Tellmegen
  • 23andMe
  • AncestryDNA
  • MyDNA
  • Everly Well
  • Igenomix
  • VitaGen
  • Myriad Genetics Inc
  • Mapmygenome
  • Helix OpCo LLC
  • MyHeritage Ltd
  • Illumina Inc

The Genetic Testing Market size is expected to reach USD 122.83 Billion in 2034 from USD 19.08 Billion (2025) growing at a CAGR of 22.99% during 2026-2034.

The global genetic testing market is witnessing strong growth due to the increasing demand for personalized medicine and early disease detection. Genetic testing analyzes DNA to identify inherited conditions, genetic mutations, and potential health risks. These tests are widely used for diagnosing genetic disorders, cancer risk assessment, prenatal screening, and ancestry testing.

Advances in genomic technologies, particularly next-generation sequencing, have significantly improved the speed and accuracy of genetic testing. Healthcare providers are increasingly using genetic data to develop targeted treatment plans and predict disease susceptibility. The growing awareness of preventive healthcare and expanding access to genetic testing services are also contributing to market expansion.

In the future, the genetic testing market is expected to grow rapidly as precision medicine becomes more widely adopted. Increased investments in genomic research and declining sequencing costs will make genetic testing more accessible. As healthcare systems focus more on personalized treatments, genetic testing will become an essential component of modern medicine.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• Next Generation Sequencing
• Array Technology
• PCR-based Testing
• FISH
• Others

By Application

• Ancestry & Ethnicity
• Traits Screening
• Genetic Disease Carrier Status
• New Baby Screening
• Health and Wellness

By Product

• Consumables
• Equipment
• Software & Services

By Channel

• Online
• Offline

By End Use

• Hospitals & Clinics
• Diagnostic Laboratories
• Others

COMPANIES PROFILED

• 24Genetics, Circle DNA, Tellmegen, 23andMe, AncestryDNA, MyDNA, Everly Well, Igenomix, VitaGen, Myriad Genetics Inc, Mapmygenome, Helix OpCo LLC, MyHeritage Ltd, Illumina Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL GENETIC TESTING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. Next Generation Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Array Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. PCR-based Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. FISH Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GENETIC TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Ancestry & Ethnicity Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Traits Screening Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Genetic Disease Carrier Status Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GENETIC TESTING MARKET: BY NEW BABY SCREENING 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast New Baby Screening
• 6.2. Health and Wellness Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GENETIC TESTING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Product
• 7.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Equipment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Software & Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL GENETIC TESTING MARKET: BY CHANNEL 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Channel
• 8.2. Online Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Offline Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL GENETIC TESTING MARKET: BY END USE 2022-2034 (USD MN)

• 9.1. Market Analysis, Insights and Forecast End Use
• 9.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL GENETIC TESTING MARKET: BY REGION 2022-2034(USD MN)

• 10.1. Regional Outlook
• 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.2.1 By Technology
  • 10.2.2 By Application
  • 10.2.3 By New Baby Screening
  • 10.2.4 By Product
  • 10.2.5 By Channel
  • 10.2.6 By End Use
  • 10.2.7 United States
  • 10.2.8 Canada
  • 10.2.9 Mexico
• 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.3.1 By Technology
  • 10.3.2 By Application
  • 10.3.3 By New Baby Screening
  • 10.3.4 By Product
  • 10.3.5 By Channel
  • 10.3.6 By End Use
  • 10.3.7 United Kingdom
  • 10.3.8 France
  • 10.3.9 Germany
  • 10.3.10 Italy
  • 10.3.11 Russia
  • 10.3.12 Rest Of Europe
• 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.4.1 By Technology
  • 10.4.2 By Application
  • 10.4.3 By New Baby Screening
  • 10.4.4 By Product
  • 10.4.5 By Channel
  • 10.4.6 By End Use
  • 10.4.7 India
  • 10.4.8 Japan
  • 10.4.9 South Korea
  • 10.4.10 Australia
  • 10.4.11 South East Asia
  • 10.4.12 Rest Of Asia Pacific
• 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.5.1 By Technology
  • 10.5.2 By Application
  • 10.5.3 By New Baby Screening
  • 10.5.4 By Product
  • 10.5.5 By Channel
  • 10.5.6 By End Use
  • 10.5.7 Brazil
  • 10.5.8 Argentina
  • 10.5.9 Peru
  • 10.5.10 Chile
  • 10.5.11 South East Asia
  • 10.5.12 Rest of Latin America
• 10.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.6.1 By Technology
  • 10.6.2 By Application
  • 10.6.3 By New Baby Screening
  • 10.6.4 By Product
  • 10.6.5 By Channel
  • 10.6.6 By End Use
  • 10.6.7 Saudi Arabia
  • 10.6.8 UAE
  • 10.6.9 Israel
  • 10.6.10 South Africa
  • 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

• 11.1. Recent Developments
• 11.2. Company Categorization
• 11.3. Supply Chain & Channel Partners (based on availability)
• 11.4. Market Share & Positioning Analysis (based on availability)
• 11.5. Vendor Landscape (based on availability)
• 11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL GENETIC TESTING INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Company Profiles
  • 12.2.1 24Genetics
  • 12.2.2 Circle DNA
  • 12.2.3 Tellmegen
  • 12.2.4 23andMe
  • 12.2.5 AncestryDNA
  • 12.2.6 MyDNA
  • 12.2.7 Everly Well
  • 12.2.8 Igenomix
  • 12.2.9 VitaGen
  • 12.2.10 Myriad Genetics Inc
  • 12.2.11 Mapmygenome
  • 12.2.12 Helix OpCo LLC
  • 12.2.13 MyHeritage Ltd
  • 12.2.14 Illumina Inc